Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Psychiatry].

C Bryois1, N Nanzer, S Eliez

  • 1Hôpital de Prangins, Secteur de psychiatrie ouest du canton de Vaud. christian.bryois@inst.hospvd.ch

Revue Medicale Suisse
|March 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Internet-based interdisciplinary therapeutic group (Grupo Interdisciplinar Online, GIO) for perinatal anxiety and depression-a randomized pilot study during COVID-19.

Archives of women's mental health·2024
Same author

Internet-based interdisciplinary therapeutic group (Grupo Interdisciplinar Online, GIO) for perinatal anxiety and depression-a randomized pilot study during COVID-19.

Archives of women's mental health·2023
Same author

Safety and tolerance of combination of monoamine oxidase inhibitors and direct dopamine agonists in adults and older adults with highly resistant depression.

L'Encephale·2023
Same author

Detailed insights into the formation pathway of CdS and ZnS in solution: a multi-modal <i>in situ</i> characterisation approach.

Physical chemistry chemical physics : PCCP·2023
Same author

How do layered double hydroxides evolve? First <i>in situ</i> insights into their synthesis processes.

RSC advances·2022
Same author

Impact of the first wave of the COVID-19 pandemic on French Health students.

L'Encephale·2022
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

In 2004, a novel antipsychotic with a partial dopamine agonist mechanism showed promising clinical results and good tolerance. New drug formulations for ADHD and psychosis improved treatment options and patient adherence.

Area of Science:

  • Psychiatry and Pharmacology
  • Neuroscience

Background:

  • The year 2004 saw advancements in psychopharmacology.
  • New treatments aim to improve efficacy and patient compliance.

Purpose of the Study:

  • To highlight key pharmaceutical innovations in 2004.
  • To review new drug formulations and their clinical applications.

Main Methods:

  • Review of new drug introductions and formulations.
  • Analysis of clinical results and tolerance profiles.

Main Results:

  • Introduction of a second-generation antipsychotic with partial dopamine agonist activity, demonstrating positive clinical outcomes and favorable tolerance.
  • Development of extended-release methylphenidate for ADHD, depot risperidone for improved adherence, and intramuscular olanzapine for emergency psychiatric care.

Related Experiment Videos

  • Update on lamotrigine's benefits in bipolar depression.

    • Conclusions:

    • The innovations of 2004 expanded treatment options for psychiatric disorders.
    • New formulations offer improved delivery, adherence, and emergency management for patients.